IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 325 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $56,351,046 | +14.5% | 1,242,307 | +3.6% | 0.02% | +14.3% |
| Q2 2023 | $49,203,997 | +16.0% | 1,199,220 | +1.1% | 0.01% | +7.7% |
| Q1 2023 | $42,401,686 | -10.6% | 1,186,393 | -5.6% | 0.01% | -13.3% |
| Q4 2022 | $47,449,242 | -10.8% | 1,256,268 | +4.5% | 0.02% | -21.1% |
| Q3 2022 | $53,181,000 | +24.5% | 1,202,346 | +4.2% | 0.02% | +26.7% |
| Q2 2022 | $42,722,000 | +1.4% | 1,154,025 | +1.4% | 0.02% | +15.4% |
| Q1 2022 | $42,145,000 | +26.7% | 1,137,827 | +4.1% | 0.01% | +30.0% |
| Q4 2021 | $33,274,000 | -7.3% | 1,093,439 | +2.2% | 0.01% | -16.7% |
| Q3 2021 | $35,879,000 | +26.0% | 1,069,732 | +49.8% | 0.01% | +33.3% |
| Q2 2021 | $28,480,000 | -9.1% | 713,960 | +2.5% | 0.01% | -18.2% |
| Q1 2021 | $31,315,000 | -19.9% | 696,496 | +0.7% | 0.01% | -31.2% |
| Q4 2020 | $39,093,000 | +20.9% | 691,409 | +1.5% | 0.02% | +6.7% |
| Q3 2020 | $32,324,000 | -11.1% | 681,204 | +10.5% | 0.02% | -16.7% |
| Q2 2020 | $36,348,000 | +25.9% | 616,469 | +0.9% | 0.02% | +5.9% |
| Q1 2020 | $28,874,000 | -20.0% | 610,699 | +2.3% | 0.02% | -10.5% |
| Q4 2019 | $36,079,000 | +2.4% | 597,225 | +1.6% | 0.02% | -9.5% |
| Q3 2019 | $35,234,000 | -11.1% | 588,099 | -4.6% | 0.02% | -12.5% |
| Q2 2019 | $39,624,000 | -16.2% | 616,513 | +5.8% | 0.02% | -20.0% |
| Q1 2019 | $47,283,000 | +60.5% | 582,516 | +6.9% | 0.03% | +30.4% |
| Q4 2018 | $29,454,000 | +8.6% | 544,837 | +3.6% | 0.02% | +27.8% |
| Q3 2018 | $27,119,000 | +43.3% | 525,755 | +15.7% | 0.02% | +28.6% |
| Q2 2018 | $18,928,000 | +0.6% | 454,229 | +6.4% | 0.01% | -6.7% |
| Q1 2018 | $18,817,000 | -6.9% | 426,874 | +6.2% | 0.02% | -6.2% |
| Q4 2017 | $20,220,000 | +4.5% | 401,980 | +5.3% | 0.02% | -5.9% |
| Q3 2017 | $19,354,000 | +3.5% | 381,734 | +3.9% | 0.02% | -5.6% |
| Q2 2017 | $18,698,000 | +48.6% | 367,550 | +17.4% | 0.02% | +38.5% |
| Q1 2017 | $12,582,000 | -14.9% | 312,963 | +1.2% | 0.01% | -18.8% |
| Q4 2016 | $14,793,000 | +49.5% | 309,275 | +14.5% | 0.02% | +33.3% |
| Q3 2016 | $9,898,000 | +104.4% | 270,130 | +29.9% | 0.01% | +100.0% |
| Q2 2016 | $4,843,000 | -54.2% | 207,936 | -20.3% | 0.01% | -57.1% |
| Q1 2016 | $10,566,000 | -33.4% | 260,865 | +1.9% | 0.01% | -33.3% |
| Q4 2015 | $15,853,000 | – | 255,970 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,136 | $133,749 | 7.12% |
| Bellevue Group AG | 9,743,900 | $368,027,103 | 4.88% |
| M28 Capital Management LP | 126,300 | $4,770,351 | 4.55% |
| Sicart Associates LLC | 246,258 | $9,301,165 | 3.28% |
| Camber Capital Management LP | 1,925,000 | $72,707 | 2.49% |
| Privium Fund Management B.V. | 148,807 | $5,557,941 | 2.11% |
| Deep Track Capital, LP | 1,205,773 | $45,542,046 | 1.91% |
| BVF INC/IL | 1,121,809 | $42,370,726 | 1.79% |
| Orbimed Advisors | 1,993,600 | $75,298,272 | 1.44% |
| Parkman Healthcare Partners LLC | 141,115 | $5,329,914 | 1.42% |